| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.083 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |